New Frontier Data’s Hemp Industry Report Series Explores Cannabinoids Market Potential in the United States
June 17, 2020 09:00 AM Eastern Daylight Time
WASHINGTON–(BUSINESS WIRE)–The Hemp Business Journal, the hemp division of New Frontier Data, the global authority in data, analytics and business intelligence on the cannabis industry, releases the U.S. Hemp Market Report: Cannabinoids Edition, Volume 1 ahead of its new free Hemp Cannabinoid Webinar Series, the first in New Frontier Data’s multi-episode hemp webinar series. In partnership with Groff North America, a U.S.-based medical grade cannabis ingredient producer, and Farmacy Health, an integrated cannabis health system, the series and report provide an overview of major developments in the North American hemp cannabinoid market.
“Given that more than 3 in 5 Americans believe CBD has valid medical uses, the potential wellness value hemp may provide can no longer go unnoticed”
“Given that more than 3 in 5 Americans believe CBD has valid medical uses, the potential wellness value hemp may provide can no longer go unnoticed,” said New Frontier Data Founder and CEO Giadha A. DeCarcer. “New Frontier Data’s research and analysis indicate the market value of cannabinoids will continue to grow as consumers’ access increases and the therapeutic value of minor cannabinoids such as CBN and CBG are better understood.”
The Hemp Cannabinoid Webinar Series episodes’ topics include:
- Episode 1: “Risks & Opportunities in the Hemp-Cannabinoid Market”
- Episode 2: “The Future of Minor Cannabinoids Beyond CBD”
- Episode 3: “Innovation in CBD Food & Beverage”
Hemp Cannabinoid Series FREE REGISTRATION: https://zoom.us/webinar/register/WN_KI1E54B2RPKpyj85Rga3cQ
U.S. Hemp Market Report: Cannabinoids Edition, Volume 1, FREE DOWNLOAD: https://newfrontierdata.com/product/us-hemp-market-report-cannabinoids-edition-volume-1/
For speaking and sponsorship opportunities please contact: Sponsor@NewFrontierData.com
About New Frontier Data:
New Frontier Data is an independent, technology-driven analytics company specializing in the global cannabis industry. It offers vetted data, actionable business intelligence and risk management solutions for investors, operators, researchers and policy makers. New Frontier Data’s reports and data have been cited in over 80 countries around the world to inform industry leaders. Founded in 2014, New Frontier Data is headquartered in Washington, D.C., with additional offices in Denver, CO and London, UK.
New Frontier Data does not take a position on the merits of cannabis legalization. Rather, its mission and mandate are to inform cannabis-related policy and business decisions through rigorous, issue-neutral and comprehensive analysis of the legal cannabis industry worldwide. For more information about New Frontier Data, please visit: https://www.NewFrontierData.com.
Farmacy Health is an integrated Health System built around the science and application of cannabis as a medicine. Our organization is led by experienced physicians and leading researchers who focus on the advancements of medicine, treatment and community health through the use of cannabis and its constituents.
Groff North America
Groff NA Hemplex is a physician-owned, cannabis company focused on cultivating, processing and packaging medical grade cannabis. We process and refine cannabis for its beneficial compounds and materials to further benefit people and the planet. Hemplex specializes in science-based custom cannabinoid formulations to meet consumer and market needs. Through a combination of technology and human capital, we continue to develop innovative and proven products for our customers.